Model Number FR995-29 |
Device Problems
Crack (1135); Insufficient Information (3190)
|
Patient Problems
Aneurysm (1708); Aortic Insufficiency (1715); Aortic Regurgitation (1716); Thrombus (2101); Cusp Tear (2656)
|
Event Date 06/22/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that five years post implant of this 29mm aortic bioprosthetic valve, the valve was explanted and replaced with a 23mm non-medtronic bioprosthetic valve due to aortic insufficiency.The report indicates there was suspicion of a partial "eruption" of the prosthesis in the region of the ascending aorta with suspicion of an aneurysm with thrombus in the false lumen.Upon removal of the valve, ¿cracks¿ were noted on the valve.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Medtronic received additional information that three lesions were noted on the inside of the ascending aorta of this bioprosthetic valve; one close to the left coronary ostia (area of suspected aneurysm) and one on both the right and noncoronary sinuses.No aortic insufficiency was reported and the outside portion of the bioprosthetic valve did not have any lesions noted.The physician stated the valve was competent, however it needed to be removed due to "anatomical/surgical reasons".The physician also stated that the valve was damaged during the explant.No additional adverse patient effects were reported. if information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The device was not returned for analysis and no images were provided.Based on the reported clinical observation from the medical institution, the three lesions that were reported on the bioprosthetic valve (left coronary ostia, right sinus, and non-coronary sinus) may have potentially described a typical ¿pseudoaneurysm¿ which have historically occurred near the anastomotic site of the native coronary arteries to the valve.Medtronic conducted an extensive investigation regarding pseudoaneurysms which included re-examining the quality of the porcine tissue (tissue thickness), the tissue treatment process, and all subsequent manufacturing steps.The conclusion of medtronic¿s investigation was that pseudoaneurysm formation is not directly related to any limitations within the manufacturing process, and implant technique could be an important contributing factor.Based on the available information and with no returned product, the clinical observation of a suspected aneurysm with thrombus could not be confirmed and a conclusive root cause was unable to be determined.There was no information to indicate a device malfunction or a quality deficiency.Eval-code result added in section.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|